Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Shiv Texchem
Quarter-by-quarter operating performance
Financials of Shiv Texchem
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 334 | 859 | 1,118 | 1,535 | 2,202 | 2,776 |
| Expenses + | 317 | 843 | 1,082 | 1,477 | 2,116 | 2,640 |
| Operating Profit | 17 | 16 | 36 | 58 | 86 | 136 |
| OPM % | 5% | 2% | 3% | 4% | 4% | 5% |
| Other Income + | 1 | 7 | 1 | 2 | 3 | 6 |
| Interest | 6 | 4 | 15 | 19 | 23 | 35 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 12 | 19 | 22 | 41 | 66 | 107 |
| Tax % | 26% | 26% | 26% | 26% | 27% | 27% |
| Net Profit + | 9 | 14 | 16 | 30 | 48 | 78 |
| EPS in Rs | 108.00 | 86.62 | 100.19 | 140.86 | 20.76 | 33.58 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Shiv Texchem
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.80 | 2 | 2 | 2 | 23 | 23 |
| Reserves | 27 | 105 | 121 | 191 | 310 | 387 |
| Borrowings + | 122 | 120 | 329 | 297 | 409 | 701 |
| Other Liabilities + | 9 | 198 | 150 | 309 | 511 | 372 |
| Total Liabilities | 159 | 425 | 602 | 799 | 1,254 | 1,483 |
| Fixed Assets + | 0 | 0 | 1 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 1 | 2 |
| Other Assets + | 158 | 425 | 601 | 798 | 1,251 | 1,480 |
| Total Assets | 159 | 425 | 602 | 799 | 1,254 | 1,483 |
Financials of Shiv Texchem
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -81 | 28 | -162 | 58 | -116 | |
| Cash from Investing Activity + | 0 | -0 | -1 | -0 | -0 | |
| Cash from Financing Activity + | 95 | 61 | 193 | -11 | 181 | |
| Net Cash Flow | 15 | 88 | 30 | 47 | 65 | |
| Free Cash Flow | -81 | 28 | -163 | 58 | -116 | |
| CFO/OP | -467% | 208% | -436% | 119% | -114% |
Financials of Shiv Texchem
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 151 | 76 | 41 | 43 | 74 | 74 |
| Inventory Days | 0 | 59 | 111 | 104 | 91 | 96 |
| Days Payable | 1 | 88 | 41 | 72 | 77 | 47 |
| Cash Conversion Cycle | 150 | 47 | 112 | 74 | 87 | 123 |
| Working Capital Days | 17 | 26 | 15 | 18 | 30 | 63 |
| ROCE % | 11% | 11% | 13% | 14% | 15% |
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…